Over 1600 Total Lots Up For Auction at Four Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12

Dr. Benjamin Movsas

Society of Chairs of Academic Radiation Oncology Programs elects president
July 24, 2018
ASTRO Rad Oncology Radiation Therapy
Dr. Movsas Benjamin
DETROIT – Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at the Henry Ford Cancer Institute, has been named President of the American Society for Radiation Oncology’s (ASTRO) Society of Chairs of Academic Radiation Oncology Programs (SCAROP).

His one-year term as SCAROP President began in Summer 2018. Dr. Movsas previously served as SCAROP’s Vice President.

SCAROP is comprised of a group of national leaders in radiation oncology. The society provides a forum for the chairs of academic radiation oncology programs to discuss issues of common interest and to foster an interchange of ideas to help shape the future vision and direction of the field.
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats
Dr. Movsas is a recognized leader in radiation oncology, stereotactic radiation, lung cancer, prostate cancer, and quality of life issues pertaining to cancer.

He was recently named President-Elect of the American Radium Society (ARS); he assumes the role of ARS President in Spring 2019. He also serves as co-chair of the NCI Patient Centered Outcomes Research (PCOR) committee for the NRG clinical trial cooperative group.

He has published extensively on the topic of radiation therapy for cancer in many prestigious medical journals and regularly presents his research findings at some of the nation’s top medical meetings.

Ranked as one of American’s top cancer doctors, Dr. Movsas has been featured in Consumer’s Guide to Top Doctors, HOUR Detroit’s Top Docs, and the Castle Connolly’s America’s Top Doctors for Cancer. He also is a Fellow of both the American Society of Radiation Oncology (ASTRO) and of the American College of Radiology (ACR).

Dr. Movsas received his undergraduate degree from Harvard University and his medical degree from the Washington University School of Medicine.


About the Henry Ford Cancer Institute
The Henry Ford Cancer Institute is one of the largest cancer programs in Michigan, providing care at five hospitals and six outpatient facilities, and dozens of aligned doctor’s offices throughout southeast and southcentral Michigan. Treatment for the most complex or rare cancers and the Institute’s extensive cancer research program is anchored by Henry Ford Hospital.

You Must Be Logged In To Post A Comment

 

Rad Oncology Homepage

Will you be attending this year's National Proton Conference?
Q&A with Jennifer Maggiore, the National Association for Proton Therapy’s (NAPT) executive director
Varian and Embolx to jointly market embolization microcatheter in US
Expanding interventional oncology portfolio with a focus on liver-directed therapies
FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
Approved for patients who received one androgen receptor pathway inhibitor (ARPI) but not chemotherapy
World Theranostics Day: The dawn of precision cancer care
Insights from Dr. Ilya Gipp, oncology chief medical officer at GE HealthCare
Eckert & Ziegler to supply lu-177 to AtomVie under new global agreement
Increasingly used in targeted radiopharmaceutical therapies for various cancers
Congress reintroduces ROCR Act to reform Medicare payments for radiation therapy
Seeks to replace per-treatment reimbursement model with episode-based system
More than 16,000 more linear accelerators needed to meet global demand by 2045: study
Researchers highlight urgent need for investment in global radiotherapy infrastructure
RefleXion expands SCINTIX radiotherapy with first freestanding cancer center install
X1 platform provides biology-guided treatment in real time
University Hospitals to build $39 million regional cancer hub at UH TriPoint in Ohio
Follows similar expansions at UH Avon and UH Minoff health centers
The Case FOR radiologic detection & diagnosis versus blood, urine and hormone testing.
ProstatID: A Smarter, Non-Invasive Approach to Prostate Cancer Detection